| Q38895540 | A Review of the Role of Neurotensin and Its Receptors in Colorectal Cancer |
| Q33221326 | A novel form of neurotensin post-translationally modified by arginylation |
| Q30584554 | Activation of neurotensin receptor type 1 attenuates locomotor activity |
| Q41016202 | Activation of receptor gene transcription is required to maintain cell sensitization after agonist exposure. Study on neurotensin receptor. |
| Q40962965 | An antagonistic monoclonal antibody (B-N6) specific for the human neurotensin receptor-1. |
| Q37845684 | Anticonvulsant neuropeptides as drug leads for neurological diseases |
| Q44864832 | Automated large-scale purification of a G protein-coupled receptor for neurotensin |
| Q90720089 | Beneficial Effects of Neurotensin in Murine Model of Hapten-Induced Asthma |
| Q44260116 | Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats |
| Q28536254 | Bright fluorescence monitoring system utilizing Zoanthus sp. green fluorescent protein (ZsGreen) for human G-protein-coupled receptor signaling in microbial yeast cells |
| Q48486157 | Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain. |
| Q35041047 | Characterization of high affinity neurotensin receptor NTR1 in HL-60 cells and its down regulation during granulocytic differentiation |
| Q34110269 | Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery. |
| Q30477036 | Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance |
| Q41922306 | Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions |
| Q48472876 | Common quantitative trait loci for alcohol-related behaviors and CNS neurotensin measures: voluntary ethanol consumption |
| Q93053579 | Conformational transitions of a neurotensin receptor 1-Gi1 complex |
| Q22003900 | Correlative ultrastructural distribution of neurotensin receptor proteins and binding sites in the rat substantia nigra |
| Q39253697 | Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand |
| Q48794750 | Differential binding profile and internalization process of neurotensin via neuronal and glial receptors |
| Q48271028 | Differential ontogenetic patterns of levocabastine-sensitive neurotensin NT2 receptors and of NT1 receptors in the rat brain revealed by in situ hybridization |
| Q47973062 | Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells |
| Q28580142 | Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody |
| Q50189472 | Diverse actions of the modulatory peptide neurotensin on central synaptic transmission. |
| Q33704191 | Does neurotensin mediate the effects of antipsychotic drugs? |
| Q48962597 | Effects of SR 48692 on neurotensin-induced calcium-activated chloride currents in the Xenopus oocyte expression system: agonist-like activity on the levocabastine-sensitive neurotensin receptor and absence of antagonist effect on the levocabastine i |
| Q73455068 | Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol |
| Q28582047 | Effects of neurotensin on discharge rates of rat suprachiasmatic nucleus neurons in vitro |
| Q41442335 | Effects of pallidal neurotensin on haloperidol-induced parkinsonian catalepsy: behavioral and electrophysiological studies |
| Q46667667 | Electrophysiological evidence for putative subtypes of neurotensin receptors in guinea-pig mesencephalic dopaminergic neurons |
| Q30426586 | Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders. |
| Q37451908 | Endogenous CNS expression of neurotensin and neurotensin receptors is altered during the postpartum period in outbred mice |
| Q73964518 | Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization |
| Q48443213 | Evidence for additional neurotensin receptor subtypes: neurotensin analogs that distinguish between neurotensin-mediated hypothermia and antinociception |
| Q73103514 | Evidence for the dual coupling of the rat neurotensin receptor with pertussis toxin-sensitive and insensitive G-proteins |
| Q42241976 | Existence of two translation initiation sites leading to the expression of two proteins from the rat high-affinity neurotensin-receptor cDNA: possible regulation by the 5' end non-coding region |
| Q48270929 | Expression of the 100-kDa neurotensin receptor sortilin during mouse embryonal development |
| Q39025439 | GPR39-1b, the 5-transmembrane isoform of GPR39 interacts with neurotensin receptor NTSR1 and modifies its function |
| Q46691563 | Heightened amygdala long-term potentiation in neurotensin receptor type-1 knockout mice |
| Q48572852 | High affinity neurotensin receptor mRNA distribution in rat brain and peripheral tissues. Analysis by quantitative RT-PCR. |
| Q30475347 | Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice |
| Q40473940 | Identification and functional characterization of a 5-transmembrane domain variant isoform of the NTS2 neurotensin receptor in rat central nervous system. |
| Q34435669 | Identification of 1-({[1-(4-fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane carboxylic acid as a selective nonpeptide neurotensin receptor type 2 compound |
| Q34164864 | Identification of N-[(5-{[(4-methylphenyl)sulfonyl]amino}-3-(trifluoroacetyl)-1H-indol-1-yl)acetyl]-l-leucine (NTRC-824), a neurotensin-like nonpeptide compound selective for the neurotensin receptor type 2 |
| Q49724180 | Identification of Neurotensin Receptor Expressing Cells in the Ventral Tegmental Area across the Lifespan. |
| Q73316773 | Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1 |
| Q48319054 | Identification of the receptor subtype involved in the analgesic effect of neurotensin |
| Q44441072 | Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system |
| Q45241562 | Impact of the proline residue on ligand binding of neurotensin receptor 2 (NTS2)-selective peptide-peptoid hybrids |
| Q43832345 | Impaired G protein coupling of the neurotensin receptor 1 by mutations in extracellular loop 3. |
| Q51594469 | In Silico Investigation of the Neurotensin Receptor 1 Binding Site: Overlapping Binding Modes for Small Molecule Antagonists and the Endogenous Peptide Agonist. |
| Q35029237 | In vitro functional evidence of different neurotensin-receptors modulating the motor response of human colonic muscle strips |
| Q48456486 | In vivo studies with low doses of levocabastine and diphenhydramine, but not pyrilamine, antagonize neurotensin-mediated antinociception |
| Q34680977 | Increased ethanol consumption and preference in mice lacking neurotensin receptor type 2 |
| Q42165142 | Interaction of xenin with the neurotensin receptor of guinea pig enteral smooth muscles |
| Q44105576 | Interaction of xenin with the neurotensin receptor of guinea pig enteral smooth muscles |
| Q28211177 | Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia |
| Q37099122 | ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse |
| Q41006768 | Mechanisms of regulation of neurotensin receptors |
| Q28584277 | Modulation of the interaction between neurotensin receptor NTS1 and Gq protein by lipid |
| Q39612931 | Molecular characterization of structure and tissue distribution of chicken neurotensin receptor |
| Q34918519 | Molecular imaging of gene expression and protein function in vivo with PET and SPECT. |
| Q42541576 | Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonist |
| Q40589593 | NT agonist regulates expression of nuclear high-affinity neurotensin receptors. |
| Q30477584 | NT79: A novel neurotensin analog with selective behavioral effects |
| Q34275762 | Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? |
| Q48729574 | Neurotensin agonist induces differential regulation of neurotensin receptor mRNA. Identification of distinct transcriptional and post-transcriptional mechanisms. |
| Q35152140 | Neurotensin agonists: possible drugs for treatment of psychostimulant abuse |
| Q36540348 | Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy |
| Q36449538 | Neurotensin and its receptors in the control of glucose homeostasis |
| Q28138527 | Neurotensin and neurotensin receptors |
| Q27322643 | Neurotensin co-expressed in orexin-producing neurons in the lateral hypothalamus plays an important role in regulation of sleep/wakefulness states |
| Q46856938 | Neurotensin depolarizes cholinergic and a subset of non-cholinergic septal/diagonal band neurons by stimulating neurotensin-1 receptors |
| Q46704914 | Neurotensin enhances GABAergic activity in rat hippocampus CA1 region by modulating L-type calcium channels |
| Q40986329 | Neurotensin enhances agonist-induced cAMP accumulation in PC3 cells via Ca2+ -dependent adenylyl cyclase(s). |
| Q89713011 | Neurotensin in reward processes |
| Q34091437 | Neurotensin induces mating in Saccharomyces cerevisiae cells that express human neurotensin receptor type 1 in place of the endogenous pheromone receptor |
| Q22008527 | Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells |
| Q37461576 | Neurotensin modulates pacemaker activity in interstitial cells of Cajal from the mouse small intestine |
| Q33695438 | Neurotensin receptor type 1 regulates ethanol intoxication and consumption in mice |
| Q42489739 | Neurotensin regulates cortical glutamate transmission by modulating N-methyl-D-aspartate receptor functional activity: an in vivo microdialysis study |
| Q28579384 | Neurotensin regulates intracellular calcium in ventral tegmental area astrocytes: evidence for the involvement of multiple receptors |
| Q37417949 | Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism |
| Q77115463 | Neurotensin type 1 receptor-mediated activation of krox24, c-fos and Elk-1: preventing effect of the neurotensin antagonists SR 48692 and SR 142948 |
| Q35922475 | Neurotensin-induced proinflammatory signaling in human colonocytes is regulated by β-arrestins and endothelin-converting enzyme-1-dependent endocytosis and resensitization of neurotensin receptor 1. |
| Q39026861 | Neurotensin-produced antinociception in the rostral ventromedial medulla is partially mediated by spinal cord norepinephrine |
| Q34060785 | Neurotensin: peptide for the next millennium |
| Q41633181 | Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy. |
| Q39337728 | Oncogenic role of neurotensin and neurotensin receptors in various cancers. |
| Q36390910 | Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression |
| Q46123434 | Peripheral and central administration of xenin and neurotensin suppress food intake in rodents. |
| Q43588690 | Pharmacological properties of the mouse neurotensin receptor 3. Maintenance of cell surface receptor during internalization of neurotensin |
| Q57042701 | Pharmacological, molecular and functional characterization of glial neurotensin receptors |
| Q28575741 | Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells |
| Q28271138 | Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors |
| Q24533549 | Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding |
| Q34286857 | Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation |
| Q64102487 | Regional and Cellular Mapping of Sortilin Immunoreactivity in Adult Human Brain |
| Q36915456 | Regulation of the neurotensin NT(1) receptor in the developing rat brain following chronic treatment with the antagonist SR 48692 |
| Q30395034 | Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine |
| Q47172685 | Role of central neurotensin in regulating feeding: Implications for the development and treatment of body weight disorders |
| Q31942539 | SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells |
| Q42478437 | Sequences required for induction of neurotensin receptor gene expression during neuronal differentiation of N1E-115 neuroblastoma cells |
| Q28205453 | Sortilin/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking? |
| Q38339934 | Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo |
| Q74038553 | Stimulation of cell-surface urokinase-type plasminogen activator activity and cell migration in vascular endothelial cells by a novel hexapeptide analogue of neurotensin |
| Q42516494 | Stress-induced activation of median raphe serotonergic neurons in rats is potentiated by the neurotensin antagonist, SR 48692. |
| Q28582782 | Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat |
| Q27681431 | Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli |
| Q27674395 | Structure of the agonist-bound neurotensin receptor |
| Q42472841 | Synergistic effects of neurotensin and beta-adrenergic agonist on 3,5-cyclic adenosine monophosphate accumulation and DNA synthesis in prostate cancer PC3 cells |
| Q22003873 | The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor |
| Q35977626 | The conformation of neurotensin bound to its G protein-coupled receptor |
| Q44178878 | The effects of diphenhydramine and SR142948A on periaqueductal gray neurons and on the interactions between the medial preoptic nucleus and the periaqueductal gray |
| Q28308189 | The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay |
| Q43846382 | The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioural sensitisation in mice. |
| Q73098647 | The partial agonist properties of levocabastine in neurotensin-induced analgesia |
| Q38920728 | The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells |
| Q36544566 | The role of neurotensin in central nervous system pathophysiology: what is the evidence? |
| Q34463402 | The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs |
| Q33785381 | Therapeutic index of H1-antihistamines: example of cetirizine |
| Q47798016 | Tissue distribution and cellular localization of the levocabastine-sensitive neurotensin receptor mRNA in adult rat brain |
| Q34733947 | Transient and stable expression of the neurotensin receptor NTS1: a comparison of the baculovirus-insect cell and the T-REx-293 expression systems |
| Q77744006 | X-ray structural characterization of SR 142948, a novel potent synthetic neurotensin receptor antagonist |